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Abstract 
Microglia positively affect neural progenitor cell physiology through the release of 
inflammatory mediators or trophic factors. We previously demonstrated that reactive 
microglia foster KATP-channel expression, and that blocking this channel using glibenclamide 
administration enhances striatal neurogenesis after stroke. In the present study, we 
investigated whether the microglial KATP-channel directly influences the activation of neural 
precursor cells from the subventricular zone by using transgenic Csf1r-GFP mice. In vitro 
exposure of neural precursor cells to lipopolysaccharide and interferon-gamma resulted in a 
significant decrease in precursor cell number. The complete removal of microglia from the 
culture or exposure to enriched microglia culture also decreased the precursor cell number. 
The addition of glibenclamide rescued the negative effects of enriched microglia on 
neurosphere formation, and promoted a ~20% improvement in precursor cell number. Similar 
results were found using microglial-conditioned media from isolated microglia. Using 
primary mixed glial and pure microglial cultures glibenclamide specifically targeted reactive 
microglia to restore neurogenesis and increased the microglial production of the chemokine 
monocyte chemoattractant protein-1. These findings provide the first direct evidence that the 
microglial KATP-channel is a regulator of the proliferation of neural precursor cells under 
inflammatory conditions.  
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Introduction 
Adult neurogenesis is a multistep process involving the proliferation of neural precursor cells 
(NPCs), their differentiation into lineage-restricted immature neurons, and their progressive 
maturation into fully functional and integrated neurons. There is a constant turnover of 
neurons in the two niches of the adult brain necessary for the maintenance of specific 
functions and ongoing brain plasticity, namely the subgranular zone of the hippocampus and 
the subventricular zone (SVZ) of the lateral ventricle (Merkle et al. 2007; Toni et al. 2007).  
Microglia are the primary immune effector cells in the brain that release soluble 
factors promoting the proliferation, migration and differentiation of NPCs (Aarum et al. 
2003; Deierborg et al. 2010; Walton et al. 2006). When microglia become reactive in 
response to injury, they are generally considered to be anti-neurogenic, as they release pro-
inflammatory cytokines; however, under inflammatory conditions, they have been shown to 
be neuroprotective (Carson et al. 2006) and to enhance neurogenesis (Ekdahl et al. 2009). It 
is therefore likely that the microglial activity state depends on the balance of secreted 
molecules within the microenvironment (Perry et al. 2010).  
The sulphonylurea receptor 1 (SUR1) subunit can assemble either with the inward 
rectifying K
+
 ion channel subunits Kir6.1 or Kir6.2 to form the KATP-channel (Mikhailov et 
al. 2005) or with the transient receptor potential melastatin (Trpm4) to form the NCCa-ATP-
channel (Simard et al. 2012). SUR1-regulated channels have been shown to be expressed in 
neurons, astrocytes, oligodendrocytes and endothelial cells under ischemic conditions 
(Simard et al. 2006; Simard et al. 2012). We recently demonstrated that reactive microglia 
increased the expression of SUR1 and the KATP-channel after cerebral ischemia or after a pro-
inflammatory stimuli (Ortega et al. 2012, Ortega et al. 2013). Indeed, this and other in vitro 
studies have demonstrated that the KATP-channel regulates the cell reactive state, controls the 
release of a diversity of inflammatory mediators, such as nitric oxide, interleukin-6 (IL-6) and 
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tumor necrosis factor-alpha (TNFα), and modifies phagocytic activity (Ortega et al. 2012; 
Virgili et al. 2011). Post-ischemic administration of the SUR1 blocker glibenclamide has 
been proposed to prevent cytotoxic edema (Simard et al. 2006; Simard et al. 2012), promote 
neuroprotection (Ortega et al. 2012), enhance migration of SVZ neuroblasts towards the 
lesion core, and assist long-term cortical neurogenesis (Ortega et al. 2012; Ortega et al. 
2013). It is clear that the KATP-channel is a major component of the inflammatory response 
after brain injury; however, its role in NPC physiology under inflammatory conditions is still 
largely unknown. In the current study, we used the neurosphere assay (Reynolds and Weiss 
1992) to evaluate whether specific blockade of the microglial KATP-channel in response to 
pro-inflammatory stimuli contributes to NPC activation. 
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Materials and methods 
Animals 
To elucidate the role of the microglial KATP-channel in NPC activity we used adult (3 to 4-
month-old) C57BL/6 mice or Csf1r-GFP (MacGreen) transgenic mice, as previously 
described (Vukovic et al. 2012). All experiments were conducted according to the Australian 
Code of Practice for the Care and Use of Animals for Scientific Purposes, with approval from 
The University of Queensland Animal Ethics Committee. Animals were maintained on a 12 h 
light/dark cycle with food and water provided ad libitum. 
 
Neurosphere culture  
Mice were sacrificed by cervical dislocation. Brains were removed immediately and the SVZ 
dissected. Four to six SVZs were digested with 0.05% trypsin-EDTA (Invitrogen) at 37°C for 
7 min and the reaction was quenched with 0.014% (w/v) trypsin inhibitor (type I-S from 
soybean; Sigma-Aldrich). Following centrifugation at 100 g for 7 min, the resulting pellet 
was resuspended and washed twice in neurosphere growth medium comprised of mouse 
NeuroCult neural stem cell (NSC) basal medium, 10% mouse NeuroCult NSC proliferation 
supplement (Stem- Cell Technologies), 2% bovine serum albumin (Roche), and 2 µg/ml 
heparin (Sigma-Aldrich), 20 ng/ml purified mouse receptor-grade epidermal-like growth 
factor (BD Biosciences), and 10 ng/ml recombinant bovine fibroblast growth factor (Roche). 
The suspension was then mechanically triturated until smooth and filtered through 40 µM 
cell sieve (Falcon™; BD Bioscience) to obtain a single cell suspension. Some of the 
suspensions were further examined using fluorescence-activated cell sorting (FACS) before 
being plated. The number and size of the SVZ neurospheres were determined after 7 days in 
vitro (DIV). 
Treatment of primary neurosphere cultures. To assess the effect of glibenclamide on 
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NPC activity, fresh glibenclamide solution, ranging from fM to µM in concentration, was 
added directly to the culture medium upon plating.  
 
Differentiation of primary neurospheres 
Neurospheres established from the SVZ were plated onto glass coverslips coated with poly-
L-ornithine (Sigma) and laminin (natural mouse; Invitrogen) before being cultured in 
neurosphere differentiation medium containing mouse NeuroCult NSC basal medium, 10% 
mouse NeuroCult NSC proliferation supplements, and 100 U/ml penicillin/streptomycin 
(Invitrogen). To quantitatively analyze the multipotentiality of the neurospheres, individual 
neurospheres were selected from cultures and were allowed to differentiate for 6 days before 
analysis of differentiation markers by immunohistochemistry.  
Immuncytochemistry. Coverslips containing the differentiated neurospheres were 
rinsed gently with PBS and fixed with 4% paraformaldehyde (PFA) for 15 min at 4ºC. Fixed 
samples were for immunocytochemistry, as described previously (Vukovic et al. 2012). 
Briefly, samples were blocked (5% FCS and 5% normal goat serum in PBS containing 0.1% 
Triton X-100) for 1 h at 37°C. After rinsing, fresh solution containing anti-β-III tubulin 
mouse IgG monoclonal antibody (diluted 1:2000; Promega) or monoclonal rabbit anti-
doublecortin (DCX) antibody (1:500; Abcam) was added, and coverslips were kept at 4°C 
overnight. Samples were then incubated with Alexa Fluor-488 conjugated anti-mouse 
antibody (1:1000; Invitrogen) or Alexa Fluor-555 conjugated anti-rabbit antibody (1:1000; 
Invitrogen) for 30 min at 37°C. The slides were then coverslipped with fluorescence 
mounting medium (Dako) and DAPI (0.5 µg/ml; Invitrogen) to label nuclei. The total number 
of differentiated neurospheres containing β-III tubulin and DCX expressing cells were 
counted. Data were expressed as the percentage of total neurospheres containing <25, 25–
100, 100–200 or >200 β-III tubulin-positive or DCX-positive cells present in each 
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differentiated neurosphere.  
 
Fluorescence-activated cell sorting and generation of primary neurosphere culture 
To either deplete or collect microglia from SVZ cultures, dissociated cells from Csf1r-GFP 
transgenic mice were sorted using a FACS Vantage SE DiVa sorter (BD Bioscience). Four to  
six SVZs were used per preparation to obtain a single-cell suspension, as described above. 
 Snapshots of GFP
pos
 SVZ microglia were obtained using AMNIS ImageStream 100. To 
assess the effect of glibenclamide on neurosphere cultures in either the presence or absence 
of microglial cells, we used three different approaches: (1) GFP
pos
 cells (microglia) were 
removed from the cell culture (microglia-depleted cultures; -MO) and plated in 200 µl/well 
of complete neurosphere medium (~5,000 events/well or ~16,000 events/cm
2
); (2) the control 
SVZ preparations were passed through the cell sorter and all cell populations were collected 
(containing ~10% of microglial cells; +MO) and plated in 200 µl/well of complete medium 
(~16,000 events/cm
2
); (3) Enriched microglial cultured was obtained by combination of 
control SVZ preparations (~16,000 events/cm
2
) plated in 100 µl/well of complete medium 
with 100 µl of the GFP
pos
 cells (~16,000 events/cm
2
) derived from cortical samples. Primary 
neurospheres were incubated for 7 days to permit neurosphere formation and the number and 
size of the SVZ neurospheres were measured.  
Activation and treatment of fluorescence-activated cell sorting cultures. To characterize 
whether blockade of the microglial KATP-channel instructs SVZ neurogenesis, we performed 
primary neurosphere cultures either in the presence (+MO) or absence (-MO) of microglia, 
or, alternatively, in an environment with an increased number of microglia. Cultures were 
activated using 0.1 µg/mL recombinant lipopolysaccharide (LPS, Sigma-Aldrich) and 0.05 
ng/mL recombinant mouse interferon gamma (IFNγ; R&D), both of which were diluted in 
complete culture media. At the same time, all cultures were co-treated with fresh 
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glibenclamide solution diluted in complete culture media and added until the desired final 
concentration was achieved (DMSO final concentration <0.05%).  
MHCII staining. To assess microglial activation, MHCII-positive cells were quantified, 
analyzed, and sorted using FACS. In brief, cells were incubated with unconjugated rat anti-
CD16/32 (1:100; BD PharMingen) for 5 min at RT, followed by incubation with anti-I-A/I-E 
antibody (1:200) for 15 min at RT. The cells were washed once in fresh medium before 
analysis and/or FACS. 
 
Microglial-conditioned media and generation of primary neurosphere culture 
To obtain the microglial-conditioned media, cortical GFP
pos
 cells were collected (n = 4 to 6) 
by cell sorting, as described above, and harvested in 15 mL Falcon™ tubes to a final 
concentration of 100,000 cells/mL. FACS-isolated GFP
pos
-microglia were cultured for 24 h in 
the presence of either LPS+IFNγ, glibenclamide (KATP-channel blocker) or diazoxide (KATP-
channel opener), all of which were diluted in complete culture media until the desired final 
concentration was achieved (DMSO final concentration <0.05%). Diazoxide was added at a 
concentration of 50 µM (Virgili et al. 2011) either alone or in combination with 
glibenclamide. Following centrifugation at 100 g for 15 min, we collected the microglial-
conditioned media to perform the neurosphere assay, as described above. Aliquots of 
conditioned media were kept at -20°C to determine the concentration of soluble 
cytokine/chemokine. Primary neurosphere cultures in the presence of microglial-conditioned 
media were incubated for 7 days in humidified 5% CO2 to allow neurosphere formation. 
After incubation, the number and size of the neurospheres were measured.  
 
Primary glial cultures  
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Primary glial cultures were obtained as described previously (Saura et al. 2003b). Mixed glial 
cultures from 2 to 4-day-old C57BL/6 mice were obtained from the cerebral cortex (n = 6 to 
8) and digested using 0.25% trypsin-EDTA solution (Invitrogen) for 30 min at 37ºC. 
Trypsinization was stopped by adding an equal volume of culture medium, consisting of 
DMEM:F12 (Invitrogen) supplemented with 10% FBS, 0.1% penicillin-streptomycin 
(Invitrogen), 0.5 mg/mL amphotericin B (Fungizone®, Invitrogen), and 0.04% 
deoxyribonuclease I (Sigma-Aldrich). Cells were pelleted (8 min, 200 g), resuspended in 
culture medium, and brought to a single cell suspension by pipetting vigorously and filtering 
through a 105 µm-pore mesh. Cells suspensions were seeded in 24-well plates at a density of 
3x10
5
 cells/mL (~78,000 cells/cm
2
) and the medium was replaced every 7 days.  
To assess the effect of astrocytes on neurospheres, half of the wells were processed as 
mixed glial cultures (~250,000 cells/cm
2
) and half were sorted to obtain pure-microglial 
cultures using the mild trypsinization method after 19–21 DIV, as described by Saura and 
colleagues (2003b). After the astroglial layer was removed, microglia were cultured for 24 h 
in complete medium. To assess the purity of the microglial culture, cells were fixed with 4% 
PFA for 15 min at 4ºC and immunocytochemistry was carried out with an anti-Iba1 (ionized 
calcium binding adaptor molecule 1; 1:500; Wako Chemical) primary antibody and a goat 
anti-mouse Alexa Fluor-488 secondary antibody (1:500; Molecular Probes). The purity of the 
cultures was 98±1% (n = 5 cultures), based on the number of Iba1-positive cells (~20,000 
Iba1-positive cells/cm
2
). 
Activation of primary glial cultures. Primary mixed glial or primary microglial cultures 
were activated for 24 h in the presence of LPS+IFNγ. At the same time, cultures were co-
treated for 24 h with fresh glibenclamide or diazoxide solution, as described above. 
Immuncytochemistry to detect the KATP-channel. To assess the expression of the KATP-
channel in the pure microglia, immunocytochemistry was carried out on 4% PFA fixed cells 
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with a rat anti-CD68 antibody (1:500; Abcam) combined with a goat anti-SUR1 (1/100; 
Santa Cruz), rabbit anti-Kir6.1 or anti-Kir6.2 (1/400; Alomone Labs) primary antibodies. As 
secondary antibodies, we used goat anti-rat Alexa Fluor-488 and anti-rabbit/goat Alexa 
Fluor-488 (1:500; Molecular Probes).  
 
Neuronal Culture 
We used embryonic neuronal cultures to determine whether glibenclamide influenced NPC 
survival. Hippocampi from E16 to E18 C57BL/6 mice were isolated (n = 6 to 8), minced and 
digested using 0.05% trypsin-EDTA solution (Invitrogen) for 15 min at 37ºC. Digestion was 
halted by adding an equal volume of trypsin-inhibitor (Invitrogen) and spinning the solution 
for 5 min at 104 g. The cell pellet was then suspended in 1 ml DMEM:F12 media (Gibco), 
and cells were passed through a 19-gauge needle and then a 23-gauge needle. The cell 
suspension was filtered through a mesh 40 µM in diameter before being diluted in complete 
culture media containing glibenclamide. Cells were plated onto glass coverslips previously 
coated with poly-L-ornithine (Sigma) to a final density of 100,000 cells/well. Culture media 
supplemented with glibenclamide was changed after 24 h. Immunofluorescence was carried 
out after 7 DIV to detect β-III tubulin- and DCX-positive cells as described above. To count 
the number of β-III tubulin and DCX-expressing cells, five random pictures/well were taken 
using a Zeiss inverted microscope, and images were analyzed using ImageJ 1.39u (NIH, 
USA). 
 
Cytometric Bead Array (CBA)  
To quantify the concentration of releasing cytokines in the conditioned media derived from 
the pure primary microglia cultures, IL-6, TNFα, IL-12p70, IFNγ and CCL2 were assayed 
using the cytometric bead array (CBA) reagents (BD Biosciences) with four-color FACS 
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Calibur flow-cytometer (BD Biosciences), following manufacturer instructions. The analysis 
of BD CBA data was performed using the FCAP array software provided by the 
manufacturer (BD Bioscience). 
 
Statistical analysis 
Data were subjected to statistical analysis using the GraphPad Prism software (version 5.0c). 
All experiments were subjected to statistical analyses using a one-way ANOVA followed by 
the Bonferroni post hoc test for pair wise group comparisons. Values are presented as mean ± 
standard error of the mean (SEM), with significance determined at p<0.05. 
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Results 
 
Microglial KATP-channel blockade restores neural precursor cell activation after 
inflammation 
Using the Csf1r-GFP transgenic mouse, we selectively isolated microglia using fluorescence-
activated cell sorting (FACS) (Figure 1A). Examples of individual snapshots of GFP
pos
 cells 
taken during flow cytometry are shown in Figure 1B. To confirm microglial activation by 
LPS+IFNγ, MHC-II expression was measured in GFP
pos
 isolated microglia (Figure 1C, panel 
a). Of the control GFP
pos
 microglia, 21.4±2% were also MHC-II positive and when treated 
with LPS+IFNγ this percentage increased to 44.8±5% (Figure 1C, panel b), which indicated 
microglial activation. 
We evaluated the influence of microglial activation on NPC activity by assessing the 
neurosphere formation frequency in the presence or absence of microglia. After SVZ cultures 
containing ~10% microglia (+MO) were treated with LPS+IFNγ, NPC number was 
significantly reduced, by 35.4±8%, which was in agreement with our previous findings (Li 
et al. 2010) (Figure 1D and E). A further significant decrease in neurosphere number was 
observed in cultures depleted of microglia (-MO) (49.2±6%; p<0.05 when compared to 
+MO). It therefore appeared probable that the presence of microglia at endogenous levels 
was protective of neurosphere formation. To create a similar situation to that seen after brain 
injury, where microglia are present in greater concentrations, a higher ratio (1:1) of GFP
pos
 
(microglia) to GFP
neg
 cells was added to the SVZ neurosphere culture. After 
LPS+IFNγ treatment, the formation of neurospheres from microglial-enriched cultures was 
significantly reduced (75.6±8%; p<0.05 and p<0.01 when compared to -MO and +MO, 
respectively), indicating that an environment with enriched microglia negatively affects NPC 
activation. When the KATP-channel blocker glibenclamide (1 pM and 1 nM) was added to the 
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enriched microglial culture, we were able to almost completely overcome the inhibitory 
effect of LPS+IFNγ treatment. In the presence of 1 nM glibenclamide there was no 
difference between the three conditions treated with LPS+IFNγ. Our data indicate a trend 
toward improved recovery with increasing concentrations of glibenclamide.  
 
Microglia release a soluble factor to enhance neurogenesis 
As glibenclamide positively influences NPC formation in situations of increased microglial 
concentration, we first checked whether primary microglia expressed the KATP-channel. We 
performed double immunolabeling using anti-SUR1, anti-Kir6.1 and anti-Kir6.2 antibodies 
combined with anti-CD68 antibody as microglia/macrophage marker (Figure 2A). 
Colocalization of Kir6.1, Kir6.2 and SUR2 with CD68 labeling indicated that non-activated 
microglia (control, left panel) and also activated microglia (LPS+IFNγ, right panel) expressed 
the KATP-channel, making these cells a putative target for glibenclamide in vitro. 
We then looked at whether soluble factors had a direct effect on neurosphere 
formation and size. Conditioned media from isolated GFP
pos
 cells treated with LPS+IFNγ for 
24 h significantly reduced the number of neurospheres when added to neurosphere cultures 
by 22.2±3% (p<0.01) (Figure 2B). Conversely, cultures treated with LPS+IFNγ and 1 pM or 
1 nM glibenclamide produced significantly more neurospheres (11.4±3% and 10.3±3% 
respectively; p<0.01 in both cases) than the cultures treated with LPS+IFNγ  alone. The 
opposite effect was observed when the KATP-channel opener diazoxide was used alone 
(23.8±5%;  p<0.05 compared to glibenclamide 1 nM). Diazoxide partially reversed the effect 
of glibenclamide; however, this reduction was not significant. These data suggest that 
glibenclamide treatment triggers microglia to release soluble neurogenesis-promoting factors.  
Conditioned media from microglial cultures treated with LPS+IFNγ caused an overall 
reduction in neurosphere diameter, irrespective of whether or not they had received 
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glibenclamide treatment (p<0.01, Figure 2C). Neuronal differentiation was almost 
completely inhibited when neurospheres were cultured with conditioned media from 
microglia treated with LPS+IFNγ, with only a few β-III tubulin-positive cells observed (data 
not shown). It therefore appears that long-term exposure to pro-inflammatory signals blocks 
neuronal differentiation.  
 
Neural precursor cell activation is microglia-dependent 
To study whether the effect of glibenclamide was mediated soley by microglia, or whether 
other cells, such as astrocytes, could also be implicated in the process, we used primary 
mixed glial cultures (microglia and other cell types) and pure microglial cultures, both treated 
with LPS+IFNγ and glibenclamide for 48 h. Mixed glial cultures showed both GFAP- and 
Iba1-positive cells (75%±2 for GFAP, 20%±2 for Iba1 and 5%±1 for others), whereas 
>98±1% of cells in pure microglial cultures were positive only for Iba1 (Figure 3A). Visual 
analysis of cell morphology showed that, compared to control conditions, 
LPS+IFNγ treatment resulted in astrocytes with a greater number of wider processes and an 
extended cytoplasm, and microglia with a classical amoeboid shape (Figure 3A, right vs 
center and left panels). Cell morphology was not affected by glibenclamide (Figure 3A, right 
panels). 
Neurosphere cultures treated with conditioned supernatant from mixed glial cultures 
challenged with LPS+IFNγ showed a 75±3% reduction in neurosphere formation frequency 
compared to control (p<0.001; Figure 3B). This effect could not be rescued by treatment 
with either glibenclamide or diazoxide alone, nor in combination (p<0.001 compared to 
control). Treatment with conditioned supernatant derived from pure microglial cultures and 
LPS+IFNγ resulted in a less severe, but still significant, inhibition of neurosphere formation 
(45.3±8%; p<0.001 compared to control or p<0.01 compared to mixed glial). Conditioned 
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media from microglial cultures treated with 1 pM glibenclamide restored neurosphere 
formation in pure microglial cultures to near control levels (25.6±11%; p>0.05 compared to 
control and p<0.001 compared to mixed glial). Treatment with diazoxide alone or in 
combination with glibenclamide blocked this effect (p<0.001 compared to control). It 
therefore appears that other cell types, including astrocytes, are not mediating the 
glibenclamide-derived recovery in neurosphere formation.  
 
KATP-channel modulates the release of microglial inflammatory factors  
Having established a critical role for microglia in mediating the beneficial effects of KATP-
channel blockade after inflammatory conditions, we next sought to unravel the underlying 
molecular mechanism by which microglia regulate NPC activation under inflammatory 
conditions. To do so, we tested a panel of cytokines/chemokines that affect NPC physiology 
and found that supernatant from primary pure microglial cultures treated with LPS+IFNγ 
showed an overall increase in concentrations of TNFα, IL-6 and CCL2 (p<0.001; Figure 4). 
Detailed post hoc analysis indicated that diazoxide induced an anti-inflammatory response 
and decreased production of TNFα,  IL6 and CCL2 (p<0.001 or p<0.01 compared to 
LPS+IFNγ), whereas glibenclamide treatment enhanced microglial production of CCL2 
(p<0.05 compared to LPS+IFNγ) had no observable effect on IL10 or IL12p70 (data not 
shown). These results indicate that the microglial KATP-channel mediates the release of 
cytokines/chemokines or other neurotrophic factors that can modulate neurogenesis. 
 
KATP signaling does not stimulate precursor activation under physiological conditions 
We next wanted to elucidate whether neurosphere formation under physiological conditions 
is affected by glibenclamide as observed under inflammatory conditions. We treated SVZ-
derived neurosphere cultures (containing ~10% microglia) with glibenclamide or diazoxide 
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and found that neither neurosphere number (Figure 5A) nor size (Figure 5B) were 
affected. We also assessed whether glibenclamide affected NPC differentiation, and found 
that in the presence of resting microglia, the total number of neurospheres containing either 
β-III tubulin-positive cells or DCX-positive cells was similar in glibenclamide treated and 
control cultures (data not shown). Glibenclamide-treated groups (10 fM or 1 nM) moderately 
increased the number of neurospheres containing a higher number of β-III tubulin-positive 
cells (25 to 100 cells/neurosphere) by 17.8±5% and 17.3±7%, respectively (p<0.05), and also 
increased the number of neurospheres containing DCX-expressing cells by (100 to 200 
cells/neurosphere) by 14.6±4%; (p<0.05) (Figure 5C and G – left panel). To ensure that 
resting microglial cells were directing this effect, we performed another set of experiments 
removing all GFP
pos
 microglia using FACS. In the absence of microglia, the NPC 
differentiation profile was unaltered for cultures treated with glibenclamide (Figure 5D). Due 
to the known neuroprotective characteristics of glibenclamide in vivo (Ortega et al. 2012), we 
wanted to confirm that the increased number of β-III tubulin- and DCX-positive cells was not 
due to activation of neuronal survival mechanisms. We therefore cultured embryonic 
hippocampal neurons in the presence of increasing doses of glibenclamide; however, after 7 
DIV, no influence on the total number of neurons expressing β-III tubulin or DCX was 
observed (Figure 5E, F and G – right panel). 
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Discussion 
It has been suggested that immunological control of neural stem cell physiology and the dual 
role of microglia is paramount in mediating neurogenesis after brain injury. In the present 
study we explored whether the microglial KATP-channel influences adult NPC activity under 
pro-inflammatory conditions. We used a novel ex vivo model system using Csf1r-GFP 
transgenic mice, as described by Vukovic and colleagues (2012), whereby microglia could be 
selectively depleted or isolated and subsequently added to neurosphere cultures. We were 
able to show that blockade of the microglial KATP-channel restored the reduction in NPC 
number normally observed after inflammation and that this recovery was a consequence of 
the release of soluble factors.  
 
The KATP-channel has a key role in the degree of microglial-derived inflammation 
After brain injury, reactive microglia present a variety of phenotypes that each influence NPC 
physiology and neurogenic processes in different ways (Kettenmann et al. 2011). Systemic or 
central administration of LPS is a common method to activate microglia, as well an 
inflammatory response, and LPS-activated microglia and its conditioned medium has been 
shown to reduce neural stem cells survival and inhibit neural differentiation in vitro (Cacci et 
al., 2008; Monje et al., 2003). Thus, we used LPS+IFNγ to activate microglia, which in turn 
caused a reduction in NPC activation and neuronal differentiation. Interestingly, high 
inhibition of NPC activation was seen as a result of exposure to cultures with enriched 
concentrations of microglia, most likely due to an excessive production of pro-inflammatory 
mediators, which are detrimental for NPC proliferation. Similar findings were described by 
Picard-Riera and colleagues (2002) who observed that an exacerbated inflammatory response 
is complicated, strengthening the inhibition of NPC proliferation, stimulating migration, and 
enhancing astro- or oligodendrogenesis (Picard-Riera et al. 2002). Our results using 
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conditioned media derived from the primary microglial culture (>98% purity) or pure isolated 
GFP
pos
-microglia (100% purity) also point toward activated microglia exerting the observed 
effect. Our data confirm that neurogenesis is a microglial-dependent process, where microglia 
are required for NPC activation, and uncontrolled microgliosis is detrimental for 
neurogenesis. 
 
Microglial KATP-channel blockade fosters neural precursor cell activation through a 
soluble factor 
Microglia have positive and negative regulatory effects as constituents of the neurogenic 
niche (Morrens et al., 2012). In the pathogenic brain, microglia produce trophic factors with a 
positive effect on neurogenesis (Butovsky et al. 2006). As LPS+IFNγ does not enhance 
microglial proliferation in vitro (Kloss et al. 1997; Palwinder et al. 2006), and after a brain 
insult, microglia proliferate and migrate from the surrounding tissue towards the site of 
injury, increasing their cell density in the affected area, we used enriched microglial cultures 
to resemble this inflammatory situation. Given that in our neurosphere cultures, 
approximately 10% of the cells are microglia (Vukovic et al. 2012) and that conditioned 
media from primary reactive microglia treated with glibenclamide and microglial enriched 
cultures reversed the inhibition of neurogenesis caused by LPS+IFNγ treatment, it seems that 
at least a certain number of microglial cells is necessary to respond to glibenclamide and 
produce enough trophic factors to reverse the inhibition of neurogenesis. Thus, by controlling 
the reactive phenotype of reactive microglia through the blockade of the KATP-channel, we 
were able to restore neurogenesis through a process that did not require cell-cell contact. 
Walton and colleagues (2006) and Deierborg and colleagues (2012) each demonstrated that 
microglial-conditioned media restores SVZ neurogenesis and directs their differentiation into 
mature neurons. Furthermore, several studies have shown that microglia secrete a number of 
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mitogens that positively regulate the proliferation of NPCs in the SVZ (Yan et al. 2006; Jin et 
al. 2002; Aguado et al. 2005), which can have autocrine and paracrine actions. By 
characterizing cytokine release from primary microglial cultures, we found that blocking the 
KATP-channel increased the secretion of MCP-1. This chemokine does not directly activate an 
inflammatory response in microglia nor causes neuronal damage (Hinojosa et al. 2011); 
however, it can enhance NPC differentiation (Turbic et al. 2011; Liu et al. 2007). Our 
previous findings in vivo demonstrate that glibenclamide increased migration of 
doublecortin-positive striatal cells toward the lesion after cerebral ischemia (Ortega et al. 
2013), where MCP-1 has a major role. The enhanced NPC activation observed in the current 
study is unlikely to be a consequence of MCP-1 action alone and further cytokine analysis is 
necessary to reveal the mechanism by which the microglial KATP-channel blockade enhances 
NPC activation. 
As glibenclamide binds to SUR1, which forms both the KATP-channel and the 
astroglial NCCa-ATP-channel expressed under pathological conditions (Ortega et al. 2012; 
Ortega et al. 2013; Simard et al. 2006), we wanted to further explore the relationship between 
enhanced neurogenesis and the microglial KATP-channel and the astroglial NCCa-ATP-channel. 
We found that conditioned media from mixed glial cultures markedly blocked NPC 
activation, an effect that could not be rescued by glibenclamide treatment. These results are 
in line with studies using experimental cerebral ischemia models, where the NCCa-ATP channel 
was involved in the resolution of the cytotoxic edema (Simard et al. 2006; Simard et al. 
2012). It appears that the astroglial NCCa-ATP channel, although capable of reversing the 
cytotoxic edema after ischemia, does not contribute to the glibenclamide-dependent rescue of 
neurogenesis (Ortega et al. 2013). Also, as more proliferative microglia were present in 
mixed glial cultures than in microglial cultures, it is therefore possible that astrocytes in 
mixed glial cultures use a positive feedback mechanisms to strengthen the pro-inflammatory 
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response derived from microglia (Losciuto et al, 2013; Saura et al. 2003a). Indeed, NPC 
inhibition could be a consequence of an excessive production of pro-inflammatory factors 
mediated by microglia; however, as reactive microglia express the KATP-channel (Ortega et 
al. 2012; Ortega et al. 2013), a glibenclamide-derived response would have also been 
expected in this scenario.  
 
Treatment of microglia with diazoxide does not correlate with enhanced precursor cell 
activation in vitro  
Previous studies established a pro-neurogenic role for microglia in both the SVZ and 
subgranular zone (Mcpherson et al. 2011; Thored et al. 2009). In our study, microglial-
conditioned supernatant treated with diazoxide, a well-known anti-inflammatory KATP-
channel opener (Virgili et al. 2011; Zhou et al. 2008), presented a lower concentration of 
inflammatory mediators but did not foster NPC activation. Our results align with previous 
studies showing that anti-inflammatory minocycline treatment, does not cause any changes in 
neurogenesis (Ng et al., 2012), or lead to a reduction in NPC proliferation of SVZ progenitors 
after inflammation (Kim et al. 2009; Deierborg et al., 2010). On the contrary, although 
glibenclamide did not modify the release of IL-6 and TNFα, it was able to enhance activation 
of NPCs. Thus, rather than modifying the microglial inflammatory phenotype, the 
glibenclamide effect most likely resulted from the modification of the release of specific pro-
neurogenic factors. Studies of the specific role of inflammatory cytokines have shown 
conflicting results in central nervous system pathogenesis and neurogenesis, supporting the 
view that the effects of inflammatory cytokines are dose- and context-dependent (Bernardino 
et al. 2008; Bowen et al. 2011; Lambertsen et al. 2009; Veroni et al. 2010). In addition, the 
finding that cyclooxigenase-2 inhibitors, which are highly expressed by reactive microglia, 
are potent suppressors of neurogenesis (Goncalves et al., 2010) indicates that anti-
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inflammatory therapies may not all be beneficial for restoring neurogenesis. Our findings 
reinforce the idea that some pro-inflammatory modulators, such as IL-6 and TNFα, do not act 
as major negative regulators of adult neurogenesis per se. Thus, as microglial activation 
mediates inflammation at the site of injury and in the lesion (Graeber and Streit 2010) and 
NPCs from the SVZ respond positively to inflammatory mediators (Ekdahl et al. 2009; 
Macas et al. 2006; Zhang et al. 2008), under some conditions, therapies focusing on 
abrogating inflammation would be detrimental for NPC proliferation. 
In summary, our findings provide evidence that blockade of the microglial KATP-
channel causes the release of soluble factors that enhance NPC proliferation and partially 
modifies cell fate determination. Also, we demonstrate that the microglial KATP-channel can 
modulate microglial release of MCP-1. Therefore, modulation of the reactive microglial state 
and the release of inflammatory cytokines and trophic factors through pharmacological 
manipulation of the KATP-channel represent a possible alternative for the treatment of brain 
and central nervous system injury. 
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Figure Legend 
 
Figure 1. Inhibition of neurosphere formation is reversed by microglial KATP-
channel blockade in vitro. Csf1r-GFP transgenic mice were used and (A) the GFP
pos
 
population (microglia) was sorted using FACS. (B) Photomicrographs of single GFP
pos
 
cells from dissociated Csfr1-GFP cortex taken during flow cytometry. (C) FACS 
analysis of MHC-II expression levels from isolated microglia (a) or after 24 h 
LPS+IFNγ treatment (b). (D) An overall reduction in neurosphere number was observed 
after LPS+IFNγ (L+I) treatment in all conditions when compared to control (p<0.01; n 
= 3 to 4 per experimental condition). Glibenclamide (Gbc) reversed the inhibitory effect 
of the enriched microglial culture in a dose-dependent manner. (E) Representative 
image of SVZ neurospheres. (Results are shown as mean ± SEM; one-way ANOVA 
followed by the Bonferroni post hoc test; *p<0.05 and **p<0.01; scale bar in E = 150 
µm, and E insert = 50 µm).  
 
Figure 2. Microglia express the KATP-channel and modulate neurogenesis through 
a soluble factor. (A) Representative photomicrographs of pure microglial culture in 
control conditions (left panel) or after 24 h of activation with LPS+IFNγ (right panel). 
The KATP-channel components Kir6.1, Kir6.2 and SUR1 (red) were colocalized with 
microglial cells CD68 (green), and counterstained with DAPI (blue). The GFP
pos
 cell 
population was collected from Csf1r-GFP transgenic mice by cell sorting and cultured 
for 24 h in the presence of LPS+IFNγ (L+I), glibenclamide (Gbc) and/or diazoxide 
(Dz). The conditioned-media from these cells was then used to perform neurosphere 
cultures. (B) Conditioned media of microglia treated with glibenclamide was able to 
restore the inhibition of neurosphere formation caused by L+I (p<0.01 at 1 pM and 1 
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nM Gbc). Diazoxide reversed this effect (p<0.05 compared to Gbc 1 nM). At 1 nM 
glibenclamide, this reduction was not significant (n = 3 to 7 per experimental 
condition). Dotted line represents control group. (C) Overall reduction in neurosphere 
size after treatment with L+I. Glibenclamide treatment did not affect neurosphere size 
(n = 5–7 per experimental condition). (Results are shown as mean ± SEM; one-way 
ANOVA followed by the Bonferroni post hoc test; *p<0.05 and **p<0.01; scale bar = 
20 µm). 
 
Figure 3. Absence of astrocytes increased neural precursor cell activation. (A) 
Representative photomicrographs of mixed glial or pure microglial culture after 24 h of 
LPS+IFNγ (L+I) and glibenclamide (Gbc; 1 pM) treatment. Microglial cells were 
immunostained for Iba1 (green), astrocytes for GFAP (red), and counterstained with 
DAPI (blue). (B) Conditioned supernatant from mixed glial cultures challenged with 
LPS+IFNγ caused a 75±3% reduction in neurosphere formation frequency, while 
supernatant derived from pure microglial cultures and LPS+IFNγ caused a 45.3±8% 
decrease (p<0.001 compared to control in both cases). Pure microglial-conditioned 
media treated with 1 pM glibenclamide restored neurosphere formation to near control 
levels. This positive effect was blocked by diazoxide alone and when combined with 
glibenclamide (p<0.001 compared to control in both cases; n = 5 per experimental 
condition). (Results are shown as mean ± SEM; one-way ANOVA followed by the 
Bonferroni post hoc test; ***p<0.001 (vs control conditions), 
##
p<0.01, 
###
p<0.001 (vs 
pure microglia cultures); dotted line in B represents control group = 100%; scale bar = 
50 µm).  
 
Figure 4. Microglial KATP-channel blockade increased the production of the MCP-
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Quantification of microglial-released cytokines and inflammatory mediators from 
primary pure microglial-conditioned media showed that LPS+IFNγ (L+I) treatment 
increased the overall production of IL-6, TNFα and MCP-1 (p<0.001) and the addition 
of diazoxide (Dz) reversed this effect. Glibenclamide at 1 pM boosted the production of 
MCP-1 when compared to LPS+IFNγ and 1 nM glibenclamide (n = 4 per experimental 
condition). (Results are shown as mean ± SEM; one-way ANOVA followed by the 
Bonferroni post hoc test; *p<0.05, **p<0.01, ***p<0.001). 
 
Figure 5. In the presence of microglia, neurosphere cultures produce more 
neurons after treatment with glibenclamide. (A) Neurosphere formation and (B) 
neurosphere size is unaffected by glibenclamide (Gbc) treatment (n = 4 per 
experimental condition). (C & D) Percentage of total neurospheres containing β-III 
tubulin-positive and DCX-positive cells in the presence (+MO; C) or absence (-MO; D) 
of microglia. Glibenclamide treatment resulted in more neurospheres containing a 
higher number of β-III tubulin or DCX expressing cells only in the presence of 
microglial cells (n = 4 per experimental condition). (E & F) Survival of hippocampal 
neurons labeled with β-III tubulin
 
(E) or DCX (F) was unaltered in the presence of 
glibenclamide (n = 6 per experimental condition). (G) Representative photomicrographs 
of β-III tubulin or DCX-positive cells in differentiated neurospheres in presence of 
microglia (left panel) and neuronal cultures (lower panel). (Results are shown as mean ± 
SEM; one-way ANOVA followed by the Bonferroni post hoc test; *p<0.05. Scale bar 
left panels = 120 µm, right panels = 100 µm). 
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Figure 1. Inhibition of neurosphere formation is reversed by microglial KATP-channel blockade in vitro. 
Csf1r-GFP transgenic mice were used and (A) the GFPpos population (microglia) was sorted using FACS. (B) 
Photomicrographs of single GFPpos cells from dissociated Csfr1-GFP cortex taken during flow cytometry. (C) 
FACS analysis of MHC-II expression levels from isolated microglia (a) or after 24 h LPS+IFNγ treatment (b). 
(D) An overall reduction in neurosphere number was observed after LPS+IFNγ (L+I) treatment in all 
conditions when compared to control (p<0.01; n = 3 to 4 per experimental condition). Glibenclamide (Gbc) 
reversed the inhibitory effect of the enriched microglial culture in a dose-dependent manner. (E) 
Representative image of SVZ neurospheres. (Results are shown as mean ± SEM; one-way ANOVA followed 
by the Bonferroni post hoc test; *p<0.05 and **p<0.01; scale bar in E = 150 µm, and E insert = 50 µm).  
157x249mm (300 x 300 DPI)  
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Figure 2. Microglia express the KATP-channel and modulate neurogenesis through a soluble factor. (A) 
Representative photomicrographs of pure microglial culture in control conditions (left panel) or after 24 h of 
activation with LPS+IFNγ (right panel). The KATP-channel components Kir6.1, Kir6.2 and SUR1 (red) were 
colocalized with microglial cells CD68 (green), and counterstained with DAPI (blue). The GFPpos cell 
population was collected from Csf1r-GFP transgenic mice by cell sorting and cultured for 24 h in the 
presence of LPS+IFNγ (L+I), glibenclamide (Gbc) and/or diazoxide (Dz). The conditioned-media from these 
cells was then used to perform neurosphere cultures. (B) Conditioned media of microglia treated with 
glibenclamide was able to restore the inhibition of neurosphere formation caused by L+I (p<0.01 at 1 pM 
and 1 nM Gbc). Diazoxide reversed this effect (p<0.05 compared to Gbc 1 nM). At 1 nM glibenclamide, this 
reduction was not significant (n = 3 to 7 per experimental condition). Dotted line represents control group. 
(C) Overall reduction in neurosphere size after treatment with L+I. Glibenclamide treatment did not affect 
neurosphere size (n = 5–7 per experimental condition). (Results are shown as mean ± SEM; one-way 
ANOVA followed by the Bonferroni post hoc test; *p<0.05 and **p<0.01; scale bar = 20 µm).  
199x199mm (300 x 300 DPI)  
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Figure 3. Absence of astrocytes increased neural precursor cell activation. (A) Representative 
photomicrographs of mixed glial or pure microglial culture after 24 h of LPS+IFNγ (L+I) and glibenclamide 
(Gbc; 1 pM) treatment. Microglial cells were immunostained for Iba1 (green), astrocytes for GFAP (red), and 
counterstained with DAPI (blue). (B) Cultures treated with conditioned supernatant from mixed glial cultures 
challenged with LPS+IFNγ  showed a 75±3% reduction in neurosphere formation frequency, while those 
treated with supernatant derived from pure microglial cultures and LPS+IFNγ showed a 45.3±8% decrease 
(p<0.001 compared to control in both cases). Conditioned media from microglial cultures treated with 1 pM 
glibenclamide restored neurosphere formation in pure microglial cultures to near control levels. This positive 
effect was blocked by diazoxide alone and when combined with glibenclamide (p<0.001 compared to control 
in both cases; n = 5 per experimental condition). Values are given as mean ± SEM. For pairwise group 
comparisons, a one-way ANOVA followed by the Bonferroni post hoc test was used. ***p<0.001 (vs control 
conditions), ##p<0.01, ###p<0.001 (vs pure microglia cultures). Dotted line in B represents control group 
= 100%. Scale bar = 50 µm.  
155x180mm (300 x 300 DPI)  
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Figure 4. Microglial KATP channel blockade increased the production of the MCP-1 (A) The concentration of 
microglial-released cytokines and inflammatory mediators from primary pure microglial-conditioned media 
as a result of treatment with LPS+IFNγ (L+I), glibenclamide (Gbc; KATP-channel blocker) and/or diazoxide 
(Dz; KATP-channel opener) was quantified (n = 4 per experimental condition).  LPS+IFNγ treatment 
increased the overall production of IL-6, TNFα and MCP-1 (p<0.001) and the addition of diazoxide reversed 
this effect. Glibenclamide at 1 pM boosted the production of MCP-1 when compared to LPS+IFNγ and 1 nM 
glibenclamide. Values are given as mean ± SEM. For pairwise group comparisons, a one-way ANOVA 
followed by the Bonferroni post hoc test was used. *p<0.05, **p<0.01, ***p<0.001.  
49x16mm (300 x 300 DPI)  
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Figure 5. In the presence of microglia, neurosphere cultures produce more neurons after treatment with 
glibenclamide. (A) Neurosphere formation and (B) neurosphere size is unaffected by glibenclamide (Gbc) 
treatment at a range of concentrations (n = 4 per experimental condition). (C & D) Percentage of total 
neurospheres containing β-III-tubulin and DCX positive cells in presence (+MO; C) or absence (-MO; D) of 
microglia. Note that glibenclamide treatment presented more neurospheres containing higher number of β-
III-tubulin or DCX expressing cells only in the presence of microglial cells (n = 4 per experimental 
condition). (E & F) Survival of hippocampal neurons labeled with β-III-tubulin positive cells (E) or DCX (F) 
was unaltered in the presence of glibenclamide (n = 6 per experimental condition). (G) Representative 
photomicrographs of β-III-tubulin or DCX-positive cells in differentiated neurospheres in presence of 
microglia (left panel) and neuronal cultures (lower panel). Statistics: one-way ANOVA followed by the 
Bonferroni post hoc test. *p<0.05. Scale bar for left panels = 120 µm; right panels = 100 µm.  
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